Cargando…
The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer’s Disease
Glucose uptake in the brain decreases because of normal aging but this decline is accelerated in Alzheimer’s disease (AD) patients. In fact, positron emission tomography (PET) studies have shown that metabolic reductions in AD patients occur decades before the onset of symptoms, suggesting that meta...
Autores principales: | Bukke, Vidyasagar Naik, Villani, Rosanna, Archana, Moola, Wawrzyniak, Agata, Balawender, Krzysztof, Orkisz, Stanislaw, Ferraro, Luca, Serviddio, Gaetano, Cassano, Tommaso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589651/ https://www.ncbi.nlm.nih.gov/pubmed/33086751 http://dx.doi.org/10.3390/ijms21207739 |
Ejemplares similares
-
The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2020) -
Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2021) -
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
por: Cassano, Tommaso, et al.
Publicado: (2020) -
Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task
por: Cassano, Tommaso, et al.
Publicado: (2019) -
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease
por: Sangineto, Moris, et al.
Publicado: (2023)